Contract Research & Services
Contract Research

Contract Research News

View news from other Pharmaceutical sectors:
151-165 of 2114 results
Novartis unveils results of Phase III pivotal study of Afinitor
Novartis announced results of a Phase III pivotal study showing Afinitor (everolimus) tablets reduced the risk of progression by 52% (hazard ratio [HR] = 0.48; 95% confidence interval [CI], 0.35-0.67; p<0.00001) vs placebo in patients with advanced, progressive, nonfunctional neuroendocrine tumors (NET) of gastrointestinal (GI) or lung origin.
Contract Research & Services > Contract Research > News
Taiho Oncology gets US FDA nod for Lonsurf refractory colorectal cancer drug
By PBR Staff Writer
Taiho Oncology has secured approval from the US Food and Drug Administration (FDA) for Lonsurf (trifluridine and tipiracil) to treat patients with refractory metastatic colorectal cancer (mCRC).
Contract Research & Services > Contract Research > News
RuiYi doses first patient in double-blinded trial of Gerilimzumab to treat arthritis
By PBR Staff Writer
RuiYi has dosed first patient with Gerilimzumab novel monoclonal antibody to treat rheumatoid arthritis (RA) and other autoimmune disorders.
Contract Research & Services > Contract Research > News
NMI TT Pharmaservices opens new branch in Berlin, Germany
NMI TT Pharmaservices has established a new branch at the Bayer HealthCare CoLaborator in Berlin, Germany.
Contract Research & Services > Contract Research > News
H3 Biomedicine, Selvita expand precision cancer medicine alliance
By PBR Staff Writer
H3 Biomedicine and Selvita have extended their partnership to develop breakthrough precision medicines to treat cancer, through September 2016.
Contract Research & Services > Contract Research > News
Nextera forms research collaboration with Johnson & Johnson Innovation
Nextera has entered into a research agreement with Janssen Biotech, one of the Janssen Pharmaceutical Companies of Johnson & Johnson.
Contract Research & Services > Contract Research > News
Clinigen forms alliance with Cumberland Pharmaceuticals
Clinigen Group has agreed to a strategic alliance with Cumberland Pharmaceuticals, a specialty pharmaceutical company focused on hospital acute care.
Contract Research & Services > Contract Research > News
Parexel's board approves $200m common stock buyback
PAREXEL International Corporation's board of directors has approved a stock repurchase program authorizing the repurchase of up to $200m of the company’s common stock.
Contract Research & Services > Contract Research > News
Chiltern acquires Theorem Clinical Research
Chiltern has acquired Theorem Clinical Research, strengthening its position as the largest mid-sized provider of comprehensive, yet flexible and responsive, clinical development services.
Contract Research & Services > Contract Research > News
Sernova secures commercial rights to stem cell derived technologies
Sernova has signed a license agreement with the University Health Network (UHN) of Toronto, Canada to gain exclusive worldwide rights to certain patent-pending technologies developed by distinguished UHN researchers, Cristina Nostro and Gordon Keller.
Contract Research & Services > Contract Research > News
Almost 50% of testicular cancer risk is passed down through genetic faults: Study
By PBR Staff Writer
A new study has revealed that almost half of the risk of developing testicular cancer is passed down genetically.
Contract Research & Services > Contract Research > News
Debiopharm, Solid Biosciences to explore use of Alisporivir in muscular dystrophy
By PBR Staff Writer
Debiopharm International and Solid Biosciences have collaborated to explore the use of Alisporivir (Debio 025) in muscular dystrophy.
Contract Research & Services > Contract Research > News
Concordia Healthcare to buy Amdipharm Mercury for $3.5bn
By PBR Staff Writer
Concordia Healthcare has agreed to acquire the UK-based pharmaceutical firm Amdipharm Mercury from Cinven for $3.5bn.
Contract Research & Services > Contract Research > News
Novo Nordisk, MIT to undertake research on next generation of drug delivery devices
By PBR Staff Writer
Novo Nordisk and the Langer Laboratory at the Massachusetts Institute of Technology (MIT) have collaborated to undertake research on the next generation of drug delivery devices for the administration of peptides.
Contract Research & Services > Contract Research > News
Recipharm negotiates with Alcon on manufacturing deal
Recipharm is currently in discussions with Alcon and has reached agreement in principle to enter into a long-term manufacturing agreement for a range of ophthalmology products.
Contract Research & Services > Contract Research > News
151-165 of 2114 results